Washington, DC- Senator Bill Nelson (D-FL) and Senator Marco Rubio (R-FL) introduced S. 772 on April 18th. The bill aims to "to amend the Federal Food, Drug, and Cosmetic Act to clarify the Food and Drug Administration’s jurisdiction over certain tobacco products, and to protect jobs and small businesses involved in the sale, manufacturing and distribution of traditional and premium cigars.”
The bill already has four additional cosponsors: Senator Robert Casey (D-PA), Senator Mary Landrieu (D-LA), Senator Jon Tester (D-MT) and Senator David Vitter (R-LA).
The bill seeks to prohibit the FDA from regulating the premium tobacco industry in the same way that they do the cigarette industry. The FDA has not yet differentiated premium cigars and pipe tobacco from other forms of tobacco.
Bill Spann, CEO of the International Premium Cigar & Pipe Retailers, had this to say: "If the FDA regulates the premium tobacco industry in the same way they do with other tobacco, it will be devastating, harming tens of thousands of domestic jobs and thousands of small ‘mom-and-pop’ Main Street businesses.”
The bill has been read (twice) and referred to the Committee on Health, Education, Labor, and Pensions.
This article was written by Kyle Whalen. Kyle is the Public Relations Manager for the International Premium Cigar & Pipe Retailers Association and can be reached at firstname.lastname@example.org. More information can be found online at http://t.co/23PoQtORjG.